Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Technical note
-
Reference no. IMD-3-0712
Published by: International Institute for Management Development (IMD)
Originally published in: 1997
Version: 08.04.2003
Length: 53 pages
Data source: Field research

Abstract

This note covers the competitive strategies of 12 firms in the OTC (over the counter) drug industry. The companies covered range from very large MNCs to niche players across all major regions. The purpose of the note is to allow students to appreciate the key success factors for the OTC drug business and to evaluate to what extent a global strategy is possible. Rich data for analysis is provided. To be used in conjunction with ''Note on the World OTC Drug Industry'' (IMD-3-0711), ''Winning and Losing Brands in the OTC Drug Industry'' (IMD-5-0510) and ''Ciba Self Medication Division'' (IMD-3-0713).
Location:
Industry:
Size:
Large
Other setting(s):
1995

About

Abstract

This note covers the competitive strategies of 12 firms in the OTC (over the counter) drug industry. The companies covered range from very large MNCs to niche players across all major regions. The purpose of the note is to allow students to appreciate the key success factors for the OTC drug business and to evaluate to what extent a global strategy is possible. Rich data for analysis is provided. To be used in conjunction with ''Note on the World OTC Drug Industry'' (IMD-3-0711), ''Winning and Losing Brands in the OTC Drug Industry'' (IMD-5-0510) and ''Ciba Self Medication Division'' (IMD-3-0713).

Settings

Location:
Industry:
Size:
Large
Other setting(s):
1995

Related